Immunotherapy for head and neck cancer: Recent advances and future directions

JD Cramer, B Burtness, RL Ferris - Oral oncology, 2019 - Elsevier
immunotherapy is based upon the principle that adaptations in immune surveillance and
the tumor … mutated DNA of altered proteins which are antigenic, and which serve as tumoral …

An update on the immune landscape in lung and head and neck cancers

JW Carlisle, CE Steuer, TK Owonikoko… - CA: a cancer journal …, 2020 - Wiley Online Library
alterations in the epidermal growth factor receptor (EGFR) or anaplastic lymphoma kinase
(ALK) genes were randomized to receive either pembrolizumab … are not optimal candidates for …

Immunotherapy for head and neck cancer: a paradigm shift from induction chemotherapy to neoadjuvant immunotherapy

H Shibata, S Saito, R Uppaluri - Frontiers in Oncology, 2021 - frontiersin.org
immunotherapy has the potential to enhance clinical outcomes by increasing anti-tumor
immune responses in the presence of abundant tumor-… of histologic changes is understood. …

Immunotherapy for head and neck cancer

F Sim, R Leidner, RB Bell - Oral and …, 2019 - oralmaxsurgery.theclinics.com
… toward stimulating immunity in cancer. This article reviews the immunotherapies currently in
… enhance response rates and integrate immunotherapy into the definitive-treatment setting. …

Biomarkers for immunotherapy response in head and neck cancer

N Gavrielatou, S Doumas, P Economopoulou… - Cancer treatment …, 2020 - Elsevier
… to the seven steps of Cancer-Immunity Cycle as proposed by … such as HPV, genetic alterations,
neoantigens and smoking … and neck tumours making the former better candidates for IO. …

Immunotherapy in head and neck cancer when, how, and why?

D Pereira, D Martins, F Mendes - Biomedicines, 2022 - mdpi.com
… This review aims to explore immunotherapy (immune checkpoint inhibitors (ICI), therapeutic
… and the host immune system, where modifications in immunological surveillance and the …

Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy

M Canning, G Guo, M Yu, C Myint… - Frontiers in cell and …, 2019 - frontiersin.org
… Currently, the majority of head and neck cancers present with … perceived by host immune
system as the “altered self” and … , HNSCCs represent good candidates for immunotherapy, …

The role of T-cells in head and neck squamous cell carcinoma: from immunity to immunotherapy

MPS Damasio, CS Nascimento, LM Andrade… - … in oncology, 2022 - frontiersin.org
… The intricate mechanism involved in the immunity of head and neck cancers has … The
study reports differences in immunological potency attributable to alteration of polymer and the …

Current understanding of the mechanisms underlying immune evasion from PD-1/PD-L1 immune checkpoint blockade in head and neck cancer

VC Kok - Frontiers in oncology, 2020 - frontiersin.org
… our readers a broader picture of the immunotherapy comparing classical HNSCCs to NPC.
… and proliferation, changes in metabolite- and cytokine-rich tumor microenvironments, and …

Immunotherapies and future combination strategies for head and neck squamous cell carcinoma

V Cristina, RG Herrera-Gómez, P Szturz… - International journal of …, 2019 - mdpi.com
… of cancer cells by the host immune system: the immune system … TME stromal cells are
genetically altered and differ from … with immunotherapy, potentially leading to missed opportunities